drugset / Trial / NCT01243580

AG200-15 Transdermal Contraceptive Delivery System (TCDS) of Levonorgestrel and Ethinyl Estradiol

NCT01243580

Phase 1 Completed 36 enrolled Agile Therapeutics
RandomizedCrossoverOpen-labelTreatment

Summary

Pharmacokinetics and safety of AG200-15 over two consecutive cycles of therapy will be evaluated.

Timeline

Start
2009-08
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject AG200-15 Unknown Other
Comparator Ortho-Cyclen Unknown 35 ug Oral
Comparator Ortho-Cyclen Unknown 250 ug Oral

Indications

No indication recorded.